Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T cell progenitors through its ProTcell platform to provide targeted treatments like off-the-shelf CAR T. The Company is headquartered in Paris, France, at Paris Biotech Santé.
Company Details
- Employees
- 32
- Founded
- -
- Address
- Paris Biotech Santé - Pole Innovation 29, Rue Du Faubourg Saint-Jacques, Paris,île-De-France 75014,france
- Phone
- 33680581505
- ka****@****une.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- smart-immune.com
- Keywords
- Biotechnology, Cell therapy, CAR T, Immuno-oncology, NK cells, T cells, Immune reconstitution, T cell progenitors, Lymphoid progenitors, Naive cells, HSC differentiation, Thymic selection.
- HQ
- Paris, Île-de-France
Smart Immune Questions
Smart Immune's helpline number is 33680581505
Smart Immune's website is smart-immune.com
Smart Immune's LinkedIn profile is https://fr.linkedin.com/company/smartimmune
Smart Immune has
32 employees.
View email and phone details for 32
employees at Smart Immune.
Smart Immune's industry is
Biotechnology Research
Smart Immune's top competitors are
Bioaster,
Dioxycle,
Everzom,
Ose Immunotherapeutics,
Innate Pharma,
Aqemia,
Phaxiam Therapeutics,
Treefrog Therapeutics,
Cellectis,
Whitelab Genomics.
Smart Immune's support email address is karine.rossignol@smart-immune.com
Smart Immune's categories are Biotechnology Research
Smart Immune's founding year is 2017
